Literature DB >> 3545313

A unified theory for the development of cancer.

D A Spandidos.   

Abstract

It is postulated that cancer is the result of genetic and epigenetic changes that occur mainly in stem (precursor) cells of various cell types. I propose that there are three classes of genes which are involved in the development of cancer. These are: Class I, II and III oncogenes. The classification is based on the way the oncogene acts at the cellular level to further the development of cancer. Genetic changes, that is point mutations, deletions, inversions, amplifications and chromosome translocations, gains or losses in the genes themselves or epigenetic changes in the genes (e.g. DNA hypomethylation) or in the gene products (RNA or protein) are responsible for the development of cancer. Changes of oncogene activity have a genetic or epigenetic origin or both and result in quantitative or qualitative differences in the oncogene products. These are involved in changing normal cells into the cells demonstrating a cancer phenotype (usually a form of dedifferentiated cell) in a multistep process. There are several pathways to cancer and the intermediate steps are not necessarily defined in an orderly fashion. Activation of a particular Class I or II oncogene and inactivation of a Class III oncogene could occur at any step during the development of cancer. Most benign or malignant tumors consist of a heterogeneous mixture of dedifferentiated cells arising from a single cell.

Entities:  

Mesh:

Year:  1986        PMID: 3545313     DOI: 10.1007/BF01116536

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  9 in total

1.  Microsatellite instability and loss of heterozygosity in human pterygia.

Authors:  D A Spandidos; G Sourvinos; H Kiaris; J Tsamparlakis
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  The normal human H-ras1 gene can act as an onco-suppressor.

Authors:  A Spandidos; N M Wilkie
Journal:  Br J Cancer Suppl       Date:  1988-12

Review 3.  Chemically induced skin carcinogenesis: Updates in experimental models (Review).

Authors:  Monica Neagu; Constantin Caruntu; Carolina Constantin; Daniel Boda; Sabina Zurac; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Rep       Date:  2016-03-17       Impact factor: 3.906

4.  HPV strain distribution in patients with genital warts in a female population sample.

Authors:  Daniel Boda; Monica Neagu; Carolina Constantin; Razvan Nicolae Voinescu; Constantin Caruntu; Sabina Zurac; Demetrios A Spandidos; Nikolaos Drakoulis; Dimitrios Tsoukalas; Aristides M Tsatsakis
Journal:  Oncol Lett       Date:  2016-07-22       Impact factor: 2.967

5.  High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Authors:  Vladimir I Kashuba; Tatiana V Pavlova; Elvira V Grigorieva; Alexey Kutsenko; Surya Pavan Yenamandra; Jingfeng Li; Fuli Wang; Alexei I Protopopov; Veronika I Zabarovska; Vera Senchenko; Klas Haraldson; Tatiana Eshchenko; Julia Kobliakova; Olga Vorontsova; Igor Kuzmin; Eleonora Braga; Vladimir M Blinov; Lev L Kisselev; Yi-Xin Zeng; Ingemar Ernberg; Michael I Lerman; George Klein; Eugene R Zabarovsky
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

6.  Interaction of a CD44+ head and neck squamous cell carcinoma cell line with a stromal cell-derived factor-1-expressing supportive niche: An in vitro model.

Authors:  Anne Faber; Christoph Aderhold; Ulrich Reinhart Goessler; Karl Hoermann; Johannes David Schultz; Claudia Umbreit; Ute Walliczek; Jens Stern-Straeter
Journal:  Oncol Lett       Date:  2013-11-11       Impact factor: 2.967

7.  Reflectance confocal microscopy and dermoscopy for in vivo, non-invasive skin imaging of superficial basal cell carcinoma.

Authors:  Mihaela A Ghita; Constantin Caruntu; Adrian E Rosca; Harillaq Kaleshi; Ana Caruntu; Liliana Moraru; Anca Oana Docea; Sabina Zurac; Daniel Boda; Monica Neagu; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-21       Impact factor: 2.967

8.  Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.

Authors:  Sabina Zurac; Monica Neagu; Carolina Constantin; Mirela Cioplea; Roxana Nedelcu; Alexandra Bastian; Cristiana Popp; Luciana Nichita; Razvan Andrei; Tiberiu Tebeica; Cristiana Tanase; Virginia Chitu; Constantin Caruntu; Mihaela Ghita; Catalin Popescu; Daniel Boda; Bogdan Mastalier; Nicoleta Maru; Claudiu Daha; Bogdan Andreescu; Ioan Marinescu; Adrian Rebosapca; Florica Staniceanu; Gabriela Negroiu; Daniela A Ion; Dragana Nikitovic; George N Tzanakakis; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

Review 9.  An integrative theory for cancer (Review).

Authors:  Guopei Luo; Na Liu
Journal:  Int J Mol Med       Date:  2018-11-28       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.